Related references
Note: Only part of the references are listed.Subgroup analysis in obstetrics clinical trials
Mark A. Klebanoff
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial
P. F. Pinsky et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Microbicide drug candidates to prevent HIV infection
Jan Balzarini et al.
LANCET (2007)
Male tolerance study of 1% C31G
CK Mauck et al.
CONTRACEPTION (2004)
A Phase I comparative postcoital testing study of three concentrations of C31G
CK Mauck et al.
CONTRACEPTION (2004)
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II
CK Mauck et al.
CONTRACEPTION (2004)
Microbicides - evaluating multiple formulations of C31G
R Bax et al.
CONTRACEPTION (2002)
Safety of single daily use for one week of C31G HEC gel in women
SA Ballagh et al.
CONTRACEPTION (2002)
Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women
D Wilkinson et al.
LANCET INFECTIOUS DISEASES (2002)
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial
L Van Damme et al.
LANCET (2002)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher et al.
LANCET (2001)
Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: Comparative sensitivity of primary human vaginal keratinocytes
FC Krebs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
